Please login to the form below

Breast Cancer Now

This page shows the latest Breast Cancer Now news and features for those working in and with pharma, biotech and healthcare.

NICE gives Lilly’s Verzenios chance to compete with rivals

Around 46, 000 women are diagnosed with breast cancer each year in England and Wales, of whom around 8, 000 would be eligible for treatment with a CDK4/6 inhibitor. ... Baroness Delyth Morgan, chief executive at Breast Cancer Now (pictured) welcomed

Latest news

Daily Brief: Tecentriq set for breast cancer filing, Ocrevus gets NICE thumbs down, NHS needs more cash

Our round-up from pharma, biotech and healthcaare. Tecentriq takes the lead in immunotherapy for breast cancer. ... Checkpoint inhibitor immunotherapy drugs have targeted other tumour types before turning to breast cancer, but now Roche's Tecentriq looks
Daily Brief: Amgen offers Repatha deals in Europe, will Persephone slash Herceptin use?

Baroness Delyth Morgan, Chief Executive at UK charity Breast Cancer Now (pictured) said: “This marks a really promising step towards being able to safely offer patients a much shorter course of ... Herceptin remains one of the most important
NICE backs two advanced breast cancer drugs after price cuts

Women in England and Wales with advanced breast cancer can now get access to two CDK 4/6 inhibitor drugs - Pfizer’s Ibrance and Novartis’ Kisqali - after pricing negotiations between the ... important breakthroughs for women with advanced breast
Dismay as NICE turns down first-line use of AZ's Faslodex

Baroness Delyth Morgan, chief executive at medical charity Breast Cancer Now, said the verdict was disappointing. ... New options for women with this type of breast cancer are long overdue and while fulvestrant’s ultimate survival benefit remains
Novartis claims EU approval for breast cancer drug Kisqali

Firm's CDK4/6 inhibitor can now challenge Pfizer's Ibrance in Europe. Novartis can now challenge Pfizer's blockbuster breast cancer drug Ibrance in Europe after gaining approval for its ... The EU regulator has cleared Kisqali (ribociclib) for the

More from news
Approximately 2 fully matching, plus 29 partially matching documents found.

Latest Intelligence

30 Women Leaders in UK Healthcare (part 3)

28. Baroness Delyth Morgan, Breast Cancer Now Chief Executive. Delyth has been a central figure in breast cancer charities for more than 20 years, building the sector’s voice in health ... In 2015 she oversaw the merger of her organisation Breast
Engaging the digital healthcare professional

Two days after the student midwife’s tweet, UK organisation Breast Cancer Now shared its own response to the guidance, also tweeting to Pfizer and NICE and urging them to work ... Breast Cancer Now is followed by almost 40, 000, and its tweet, which it

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer

Misconception. Reality. Pancreatic cancer is rare [8]. Although the incidence of pancreatic cancer is lower than other common cancers like breast, bowel and lung, pancreatic cancer is the 5. ... Unless substantial improvements are made now, pancreatic

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.